"paper"

Prolonged unconsciousness following severe COVID-19

Underdetection of COVID-19 cases in France threatens epidemic control

Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Happy New Year 2021 from the EAN, the Home of Neurology

Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19

Neurological Predictors of Clinical Outcomes in Hospitalized Patients With COVID-19

Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot region

The Impact of SARS-CoV-2 on Stroke Epidemiology and Care: A Meta-analysis

Comprehensive health assessment three months after recovery from acute COVID-19

Neurological manifestations associated with COVID-19: a multicentric registry

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

COVID-19 and Cerebrovascular Diseases: A Systematic Review and Perspectives for Stroke Management

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with COVID-19

Societal Impact of Pain (SIP) is an international multi-stakeholder platform. Its long-term priorities are pain indicators, pain education, pain in employment, and pain research. This year traditional SIP Stakeholder Forum was on October 28th, 2020.